Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Mol Cell Biochem. 2020 May 20;470(1-2):131–143. doi: 10.1007/s11010-020-03752-4

Table 3.

Effect of CK2 inhibition on mitochondrial Ca2+ levels

Time in min Drug (concentration in μM) Mitochondrial Ca2+ level relative to pre-treatment Mean ± SD (p)
PC3-LN4 C4–2B 22Rv1
0 DMSO 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00
TBB (80) 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00
TBB (40) 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00
TBB (20) 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00
CX-4945 (10) 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00
RU360 (10) 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00
5 DMSO 0.97 ± 0.04 1.03 ± 0.04 1.00 ± 0.00
TBB (80) 1.30 ± 0.02** 1.14 ± 0.03* 1.30 ± 0.06***
TBB (40) 1.15 ± 0.16 1.04 ± 0.02 1.22 ± 0.07***
TBB (20) 1.20 ± 0.13 1.09 ± 0.05 1.11 ± 0.03#
CX-4945 (10) 1.06 ± 0.13 1.11 ± 0.03# 1.07 ± 0.02
RU360 (10) 1.05 ± 0.03 1.00 ± 0.01 1.00 ± 0.01
10 DMSO 0.90 ± 0.02 1.04 ± 0.05 0.96 ± 0.05
TBB (80) 1.34 ± 0.11*** 1.28 ± 0.03*** 1.23 ± 0.03***
TBB (40) 1.22 ± 0.09# 1.16 ± 0.03* 1.22 ± 0.05***
TBB (20) 1.39 ± 0.04*** 1.12 ± 0.04 1.21 ± 0.03***
CX-4945 (10) 1.10 ± 0.10* 1.15 ± 0.04* 1.15 ± 0.04***
RU360 (10) 1.04 ± 0.01 1.00 ± 0.01 1.01 ± 0.01
15 DMSO 0.97 ± 0.03 1.03 ± 0.02 0.99 ± 0.01
TBB (80) 1.50 ± 0.09*** 1.29 ± 0.04*** 1.30 ± 0.06***
TBB (40) 1.29 ± 0.07*** 1.14 ± 0.06# 1.20 ± 0.03***
TBB (20) 1.37 ± 0.10*** 1.19 ± 0.03** 1.12 ± 0.05*
CX-4945 (10) 1.17 ± 0.11# 1.19 ± 0.04** 1.07 ± 0.04
RU360 (10) 1.06 ± 0.03 1.02 ± 0.04 1.03 ± 0.01

Ca2+ levels represent the change within the treatment condition relative to pre-treatment of cells with the various agents shown in the drug column. DMSO served as vehicle control while RU360 served as control inhibiting Ca2+ import into mitochondria. Mean and standard deviation are listed with p values included in parentheses:

#

p < 0.1;

*

p < 0.05;

**

p < 0.01;

***

p < 0.001